Luspatercept may induce RBC transfusion independence but also Neutrophil and platelet increases in lower-risk MDS: secondary endpoints from the MEDALIST trial
Neutrophil and platelet increases with luspatercept in lower-risk MDS: secondary endpoints from the MEDALIST trial / Garcia-Manero, G., Mufti Obe, G.J., Fenaux, P., Buckstein, R.J., Santini, V., Díez-Campelo, M., Finelli, C., Ilhan, O., Sekeres, M.A., Zeidan, A.M., Ito, R., Zhang, J., Rampersad, A., Sinsimer, D., Backstrom, J.T., Platzbecker, U., Komrokji, R.S.. - In: BLOOD. - ISSN 0006-4971. - STAMPA. - online ahead of print:(2021), pp. 0-0. [10.1182/blood.2021012589]
Neutrophil and platelet increases with luspatercept in lower-risk MDS: secondary endpoints from the MEDALIST trial
Santini, Valeria;
2021
Abstract
Luspatercept may induce RBC transfusion independence but also Neutrophil and platelet increases in lower-risk MDS: secondary endpoints from the MEDALIST trial
| File | Dimensione | Formato | |
|---|---|---|---|
|
bloodbld2021012589.pdf
Accesso chiuso
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Tutti i diritti riservati
Dimensione
863.34 kB
Formato
Adobe PDF
|
863.34 kB | Adobe PDF | Richiedi una copia |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
